Lv3
305 积分 2021-10-26 加入
Cardiorenal Disease Pathways and Treatment of Patients With Comorbid Heart Failure and Chronic Kidney Disease
15天前
已关闭
The U.S. Food and Drug Administration’s Perspective on Chimeric Antigen Receptor T-Cell Therapies for Autoimmune and Rheumatic Conditions
5个月前
已完结
Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation
5个月前
已完结
Management of Iron Deficiency in Heart Failure
7个月前
已完结
Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial
9个月前
已完结
Vericiguat on C-reactive Protein Level and Prognosis in Patients with Hypertensive Heart Failure
9个月前
已完结
Pharmacological Treatment of Heart Failure with Reduced Ejection Fraction: An Updated Systematic Review and Network Meta-Analysis
10个月前
已完结
Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial
10个月前
已完结
Left ventricular hypertrophy and myocardial fibrosis in heart failure with preserved ejection fraction: mechanisms and treatment
10个月前
已完结
Racial and Ethnic Differences in Patient Age at First Hospitalization for Heart Failure
10个月前
已关闭
皖公网安备34019202002308
